Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: Juan Carlos Kaski Clear advanced filters

  • Frailty is common in older individuals, but can occur independently of advanced age, multimorbidity or disability. In this Review, Nguyen and colleagues draw on evidence from clinical guidelines and randomized controlled trials to provide an in-depth discussion of the unique challenges associated with cardiovascular pharmacotherapy in older patients with frailty.

    • Tu N. Nguyen
    • Mark Woodward
    • Juan Carlos Kaski
    Reviews
    Nature Reviews Cardiology
    P: 1-11

  • There is considerable semantic confusion when it comes to differentiating between the array of chemically and functionally distinct progestins used therapeutically. Hermsmeyer et al. consider the research reported to date, clearly distinguishing between the cardiovascular actions of estrogen, medroxyprogesterone acetate (a synthetic progestin) and progesterone (the naturally occurring progestin).

    • R Kent Hermsmeyer
    • Theresa L Thompson
    • Juan Carlos Kaski
    Reviews
    Nature Clinical Practice Cardiovascular Medicine
    Volume: 5, P: 387-395